$6.06
0.183.06%
最終更新: Oct 2, 9:20 AM
$6.00
0.122.04%
Benzinga
Benzinga
Benzinga
月曜日, 10 05
Benzinga
© 2026 Benzinga | All Rights Reserved
ENDRA Life Sciences (NDRA) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
Quarterly Revenue (Billions)
| Metric | Q2 '26 | Q1 '26 | Q4 '25 | Q3 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.84 | $-1.23 | $-1.23 | $-1.95 |
| Actual | $0.06 | $-1.09 | $-3.25 | $-2.10 |
| Surprise | +107.1% | +11.4% | -164.2% | -7.69% |
| Revenue | ||||
| Estimate | — | — | — | — |
| Actual | $0 | $0 | $0 | $0 |
| Surprise | — | — | — | — |
| Metric | Q3 '26E | Q4 '26E | Q1 '27E | Q2 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.84 | $-0.84 | $-0.80 | $-0.76 |
| Revenue | ||||
| Consensus | — | — | — | — |
| 会計四半期 | 報告日 | 実質EPS | 推定EPS | 驚き ％ |
|---|---|---|---|---|
| Q2 | Aug 17, 2026 | $0.06 | $-0.84 | 107.1 % |
| Q1 | May 18, 2026 | $-1.09 | $-1.23 | 11.4 % |
| Q4 | Mar 31, 2026 | $-3.25 | $-1.23 | -164.2 % |
| Q3 | Nov 17, 2025 | $-2.10 | $-1.95 | -7.69 % |
| 会計四半期 | 報告日 | 実際の収益 | 推定収益 | 驚き ％ |
|---|---|---|---|---|
| Q4 | Mar 30, 2022 | $0 | $220.00K | -100.0 % |
| Q3 | Nov 15, 2021 | $0 | $50.00K | -100.0 % |